582 related articles for article (PubMed ID: 35018864)
1. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.
Koltai T; Fliegel L
J Evid Based Integr Med; 2022; 27():2515690X211068826. PubMed ID: 35018864
[TBL] [Abstract][Full Text] [Related]
2. Milk thistle in liver diseases: past, present, future.
Abenavoli L; Capasso R; Milic N; Capasso F
Phytother Res; 2010 Oct; 24(10):1423-32. PubMed ID: 20564545
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of silymarin in milk thistle seeds under drought stress.
Keshavarz Afshar R; Chaichi MR; Ansari Jovini M; Jahanzad E; Hashemi M
Planta; 2015 Sep; 242(3):539-43. PubMed ID: 25708739
[TBL] [Abstract][Full Text] [Related]
4. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases.
Abenavoli L; Izzo AA; Milić N; Cicala C; Santini A; Capasso R
Phytother Res; 2018 Nov; 32(11):2202-2213. PubMed ID: 30080294
[TBL] [Abstract][Full Text] [Related]
5. Liquid chromatography-drift tube ion mobility-mass spectrometry as a new challenging tool for the separation and characterization of silymarin flavonolignans.
Fenclova M; Stranska-Zachariasova M; Benes F; Novakova A; Jonatova P; Kren V; Vitek L; Hajslova J
Anal Bioanal Chem; 2020 Feb; 412(4):819-832. PubMed ID: 31919606
[TBL] [Abstract][Full Text] [Related]
6. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).
Kidd P; Head K
Altern Med Rev; 2005 Sep; 10(3):193-203. PubMed ID: 16164374
[TBL] [Abstract][Full Text] [Related]
7. The study of flavonolignan association patterns in fruits of diverging Silybum marianum (L.) Gaertn. chemotypes provides new insights into the silymarin biosynthetic pathway.
Martinelli T; Whittaker A; Benedettelli S; Carboni A; Andrzejewska J
Phytochemistry; 2017 Dec; 144():9-18. PubMed ID: 28863306
[TBL] [Abstract][Full Text] [Related]
8. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
Albassam AA; Frye RF; Markowitz JS
Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856
[TBL] [Abstract][Full Text] [Related]
9. Recapitulation of Evidence of Phytochemical, Pharmacokinetic and Biomedical Application of Silybin.
Islam A; Mishra A; Siddiqui MA; Siddiquie S
Drug Res (Stuttg); 2021 Nov; 71(9):489-503. PubMed ID: 34318464
[TBL] [Abstract][Full Text] [Related]
10. Silybin and its congeners: from traditional medicine to molecular effects.
Křen V; Valentová K
Nat Prod Rep; 2022 Jun; 39(6):1264-1281. PubMed ID: 35510639
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models.
Bijak M; Synowiec E; Sitarek P; Sliwiński T; Saluk-Bijak J
Nutrients; 2017 Dec; 9(12):. PubMed ID: 29240674
[TBL] [Abstract][Full Text] [Related]
12. Drug-drug interactions of silymarin on the perspective of pharmacokinetics.
Wu JW; Lin LC; Tsai TH
J Ethnopharmacol; 2009 Jan; 121(2):185-93. PubMed ID: 19041708
[TBL] [Abstract][Full Text] [Related]
13. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.
Davis-Searles PR; Nakanishi Y; Kim NC; Graf TN; Oberlies NH; Wani MC; Wall ME; Agarwal R; Kroll DJ
Cancer Res; 2005 May; 65(10):4448-57. PubMed ID: 15899838
[TBL] [Abstract][Full Text] [Related]
14. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.
Bijak M
Molecules; 2017 Nov; 22(11):. PubMed ID: 29125572
[TBL] [Abstract][Full Text] [Related]
15. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study.
Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Patrick KS; Markowitz JS
Drug Metab Dispos; 2013 Sep; 41(9):1679-85. PubMed ID: 23835761
[TBL] [Abstract][Full Text] [Related]
16. Separation and characterization of silybin, isosilybin, silydianin and silychristin in milk thistle extract by liquid chromatography-electrospray tandem mass spectrometry.
Lee JI; Hsu BH; Wu D; Barrett JS
J Chromatogr A; 2006 May; 1116(1-2):57-68. PubMed ID: 16631762
[TBL] [Abstract][Full Text] [Related]
17. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
Brantley SJ; Oberlies NH; Kroll DJ; Paine MF
J Pharmacol Exp Ther; 2010 Mar; 332(3):1081-7. PubMed ID: 19934397
[TBL] [Abstract][Full Text] [Related]
18. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.
Federico A; Dallio M; Loguercio C
Molecules; 2017 Jan; 22(2):. PubMed ID: 28125040
[TBL] [Abstract][Full Text] [Related]
19. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells.
Deep G; Oberlies NH; Kroll DJ; Agarwal R
Int J Cancer; 2008 Jul; 123(1):41-50. PubMed ID: 18435416
[TBL] [Abstract][Full Text] [Related]
20. Spatial organization of silybin biosynthesis in milk thistle [Silybum marianum (L.) Gaertn].
Lv Y; Gao S; Xu S; Du G; Zhou J; Chen J
Plant J; 2017 Dec; 92(6):995-1004. PubMed ID: 28990236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
